Metrics Contract Services Wins Multiple CMO Leadership Awards for Innovation and Regulatory Track Record
Presented by Life Science Leader for the fourth year, the CMO Leadership Awards are based on Nice Insight research into customer awareness and perception of pharmaceutical outsourcing practices.
Greenville, NC, March 05, 2015 --(PR.com)-- Metrics Contract Services has received four CMO Leadership Awards honoring its innovation and regulatory track record.
The CMO Leadership Awards are presented by Life Science Leader magazine based on pharmaceutical industry research conducted by Nice Insight. Nice Insight surveyed more than 2,300 pharmaceutical and biopharmaceutical professionals about their awareness and perception of 100-plus contract manufacturing organization and 70-plus contract research organizations.
Metrics Contract Services won after being cited among the top 10 percent of companies in the following categories: Innovation Big Pharma, Regulatory Track Record Big Pharma, Innovation Mid-Sized Pharma and Regulatory Track Record Mid-Sized Pharma.
“This year’s winners represent the CMOs that pharmaceutical and biopharmaceutical executives have voted the most reputable and capable partners to handle the challenges of safe and timely drug development,” said Ed Miseta, executive editor of Life Science Leader magazine.
John S. Ross, executive vice president of Metrics, said it was gratifying for the company to be recognized for its innovation and regulatory compliance, especially considering how much employees focus on delivering sound and practical science to clients in a safe and timely way.
“Metrics employees truly are dedicated to executing thoughtful science in a transparent and collaborative manner,” he said. “It’s rewarding to know that our clients recognize our commitment to innovation and quality.”
About Metrics Contract Services
Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide. We deliver proven scientific and operational excellence for solid oral dosage forms.
Our areas of expertise include quality formulation development; first-time-in-man formulations; Phase I-III clinical trial materials manufacturing; and analytical method development and validation services leading to commercial scale manufacturing. Our technical capabilities include highly potent, cytotoxic and unstable compounds; DEA Schedule II-V controlled substances; and products with poor bioavailability, for which we offer an impressive propriety portfolio of advanced delivery methods.
Located in Greenville, N.C., Metrics Contract Services is a proud member of the Mayne Pharma family. Learn more online.
About Mayne Pharma
Mayne Pharma is a publicly traded specialty pharmaceutical company listed on the Australian Securities Exchange. The company develops and manufactures branded and generic product globally – either directly or through distribution partners – while applying its drug-delivery expertise for contract development and manufacturing services.
Mayne Pharma has a 30-year track record of innovation and success in developing new oral drug delivery systems, and these technologies have been successfully commercialized in numerous products that have been marketed around the world. Mayne Pharma has drug development and manufacturing facilities in Salisbury, Australia, with expertise in formulating complex oral dose forms, including controlled substances, modified release products and inherently unstable compounds.
The CMO Leadership Awards are presented by Life Science Leader magazine based on pharmaceutical industry research conducted by Nice Insight. Nice Insight surveyed more than 2,300 pharmaceutical and biopharmaceutical professionals about their awareness and perception of 100-plus contract manufacturing organization and 70-plus contract research organizations.
Metrics Contract Services won after being cited among the top 10 percent of companies in the following categories: Innovation Big Pharma, Regulatory Track Record Big Pharma, Innovation Mid-Sized Pharma and Regulatory Track Record Mid-Sized Pharma.
“This year’s winners represent the CMOs that pharmaceutical and biopharmaceutical executives have voted the most reputable and capable partners to handle the challenges of safe and timely drug development,” said Ed Miseta, executive editor of Life Science Leader magazine.
John S. Ross, executive vice president of Metrics, said it was gratifying for the company to be recognized for its innovation and regulatory compliance, especially considering how much employees focus on delivering sound and practical science to clients in a safe and timely way.
“Metrics employees truly are dedicated to executing thoughtful science in a transparent and collaborative manner,” he said. “It’s rewarding to know that our clients recognize our commitment to innovation and quality.”
About Metrics Contract Services
Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide. We deliver proven scientific and operational excellence for solid oral dosage forms.
Our areas of expertise include quality formulation development; first-time-in-man formulations; Phase I-III clinical trial materials manufacturing; and analytical method development and validation services leading to commercial scale manufacturing. Our technical capabilities include highly potent, cytotoxic and unstable compounds; DEA Schedule II-V controlled substances; and products with poor bioavailability, for which we offer an impressive propriety portfolio of advanced delivery methods.
Located in Greenville, N.C., Metrics Contract Services is a proud member of the Mayne Pharma family. Learn more online.
About Mayne Pharma
Mayne Pharma is a publicly traded specialty pharmaceutical company listed on the Australian Securities Exchange. The company develops and manufactures branded and generic product globally – either directly or through distribution partners – while applying its drug-delivery expertise for contract development and manufacturing services.
Mayne Pharma has a 30-year track record of innovation and success in developing new oral drug delivery systems, and these technologies have been successfully commercialized in numerous products that have been marketed around the world. Mayne Pharma has drug development and manufacturing facilities in Salisbury, Australia, with expertise in formulating complex oral dose forms, including controlled substances, modified release products and inherently unstable compounds.
Contact
Metrics, Inc.
Karen Stinneford
919-833-9102
http://www.metricsinc.com
Karen Stinneford
919-833-9102
http://www.metricsinc.com
Contact
Categories